Skip to content

Clinical Impact of Breast Parenchyma Enhancement Pattern of Breast MRI in Patients Treated with Breast Conserving Therapy and Chemotherapy

Clinical Impact of Breast Parenchyma Enhancement Pattern of Breast MRI in Patients Treated with Breast Conserving Therapy and Chemotherapy

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
CRIS
Registry ID
KCT0001914
Enrollment
305
Registered
2016-05-09
Start date
2014-04-15
Completion date
Unknown
Last updated
2019-03-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

None listed

Sponsors

The Catholic University of Korea
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: 1. 20~ 70 old aged woman (cancer detection time based) 2. histological confirmation of invasive breast cancer 3. margin negative result at the breast conserving surgery 4. underwent breast conserving surgery 6~12 months before 5. underwent mammography, ultrasonography, and breast MRI regularly 6~12

Exclusion criteria

Exclusion criteria: 1. GFR (glomerular filtration rate) < 30 mL/min/1.73m2, or known chronic renal failure 2. Acute renal insufficiency of any intensity, either due to hepato-renal syndrome or occurring in the perioperative liver transplantation period. 3. Distant metastasis at the time of breast conserving surgery 4. Pregnant or lactating women 5. History of contraindication of contrast enhanced MRI such as claustrophobia, hypersensitivity to intravenous contrast media 6. Contraindications to the use of Gd-containing contrast agents (including subjects who are suspected for or known to have NSF) 7. History of severe allergic or anaphylactoid reaction to any allergen including drugs and contrast agents. 8. Patients unable and/or unwilling to comply with treatment or study instructions.

Design outcomes

Primary

MeasureTime frame
To make assessment on change of breast parenchyma pattern between preoperative MRI and postoperative MRI after breast conserving therapy and chemotherapy.

Secondary

MeasureTime frame
To make assessment of effect of parenchyma enhancement pattern on the breast cancer detection rate

Countries

Korea, Republic of

Contacts

Public ContactBong Joo Kang

The Catholic University of Korea

lionmain@hanmai.net

Outcome results

None listed

Source: CRIS (via WHO ICTRP) · Data processed: Feb 4, 2026